Trial | NCT01791751  Report issue

Title

Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles
Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in Agonist Triggered GnRH Antagonist in Vitro Fertilization Cycles. Phase IV, Single-centre, Open-label, Controlled Clinical Trial.

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    clomifene ...

  • Study Participants

    10
The purpose of this study is to evaluate the effect on LH levels of the 5-day CC administration during luteal phase in oocyte donors, to investigate whether the CC corrects the suppressed LH levels in the luteal phase and whether it prolongs the luteal phase in the agonist triggered antagonist cycles.
Study Started
Jun 30
2012
Primary Completion
Feb 28
2013
Study Completion
Feb 28
2013
Last Update
Feb 15
2013
Estimate

Drug Clomifene Citrate

Clomiphene citrate 100 mg daily for 5 days

Clomifene Citrate Experimental

Clomifene Citrate 50 mg

Control No Intervention

No intervention

Criteria 

Inclusion Criteria:

Oocyte donors
18-35 years old
BMI 18-29 Kg/m2
Normal basal hormonal levels
No contraceptive pill

Exclusion Criteria:

Polycystic ovarian syndrome (PCOS)
Previous participation in the study
No Results Posted